e-learning
resources
Milan 2017
Wednesday, 13.09.2017
New immune markers for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma phenotyping through CD26, CD126 and LRRC32 biomarkers: a prospective study.
J. Nieto-Fontarigo (SANTIAGO DE COMPOSTELA, Spain)
Source:
International Congress 2017 – New immune markers for asthma and COPD
Session:
New immune markers for asthma and COPD
Session type:
Oral Presentation
Number:
4847
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Nieto-Fontarigo (SANTIAGO DE COMPOSTELA, Spain). Asthma phenotyping through CD26, CD126 and LRRC32 biomarkers: a prospective study.. 4847
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE
Source: Eur Respir J 2010; 35: 54-63
Year: 2010
CD26 and CD30 expression on cord blood mononuclear cells (CBMC) and total IgE level as predictors of atopic dermatitis (AD) forming in infants: a one-year prospective birth cohort study
Source: Annual Congress 2007 - Mechanisms of asthma and allergy in young children
Year: 2007
Identification of PD-L2 on macrophages in lung cancer milieu- pilot study.
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Source: Eur Respir J 2013; 41: 330-338
Year: 2013
Asthma and chronic rhinosinusitis: comparative evaluation of IgE plasma level, CD23+ and blood eosinophils
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
The role of CD39 and CD73 expressed by regulatory T cell in the pathogenesis of asthma in mice
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
TSLP as biomarker in asthma patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Antagonists for Chemoattractant receptor-homologous molecule expressed on Th2 cells in asthma: a meta-analysis and systematic review
Source: International Congress 2018 – Asthma management
Year: 2018
The prognostic value of IFN-gamma and IL-4 cytokines ratio and CD25+ lymphocytes blood content for asthma exacerbation
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Lung involvement associated with anti-NXP2 autoantibodies: a monocentre observational French study
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Blood neutrophil pattern is associated with poor asthma control in adults from the EGEA study
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Interleukin 6 modulates the risk to develop COPD: a prospective population-based cohort study
Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept